ExpertiseUpdated on 11 September 2025
SPLITTERA in producing toxins
About
We have developed SPLITTERA®, a patented next-generation split intein platform (WO2013045632A1), recognized as the fastest and most efficient available. One of its most valuable applications is enabling the controlled in vivo production of toxic proteins and proteases, overcoming the limitations of conventional expression systems.
Field
- Biotech, Pharma and Cosmetics
Organisation
Similar opportunities
Product
- Distribution Partner
- Laboratory industry
- Pharmaceutical industry
Rosa M Osuna Aguilar
Business Development Manager at Biat Group
Jerez de la Fra., Spain
Project cooperation
CLICK CAR Breakthrough Modular CAR Technology
Rosa M Osuna Aguilar
Business Development Manager at Biat Group
Jerez de la Fra., Spain
Service
Rosa M Osuna Aguilar
Business Development Manager at Biat Group
Jerez de la Fra., Spain